BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1.Audited Standalone and Consolidated financial results for the quarter and financial year ended 31.03.2024.\r\n2.Audited standalone and consolidated accounts of the Company together with Directors and Auditors reports.\r\n3. Recommendation of Dividend, if any, for the financial year ended 31.03.2024.\r\n4.Appoinment of Internal Auditors, Cost Auditors and Secretarial Auditors for f.y ended 31.03.2024.